Patient characteristics like female sex, pre-existing mood disorders, and iron deficiency are potential risk factors, as are individual variations in drug metabolism related to Cytochrome P-450 enzymes [1,9,17]. This evidence concerns the gene CYP4F3 and Iron deficiency anemia.